Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

dr. falk pharma ag - mesalazinum - granulat - mesalazinum 1 g, cellulosum microcristallinum, hypromellosum, silica colloidalis anhydrica, acidi ethacrylici et methylis methacrylatis polymerisatum, magnesii stearas, simeticonum, methylcellulosum, acidum sorbicum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, triethylis citras, talcum, carmellosum natricum, acidum citricum, povidonum k 24-27, e 171, aromatica (vanille-creme), aspartamum 2 mg, ad granulatum, pro charta 1.86 g corresp. natrium 3.24 mg. - la colite ulcerosa - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

dr. falk pharma ag - mesalazinum - granulat - mesalazinum 1.5 g, cellulosum microcristallinum, hypromellosum, silica colloidalis anhydrica, acidi ethacrylici et methylis methacrylatis polymerisatum, magnesii stearas, simeticonum, methylcellulosum, acidum sorbicum, carmellosum natricum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, triethylis citras, talcum, acidum citricum, povidonum k 24-27, e 171, aromatica (vanille-creme), aspartamum 3 mg, ad granulatum, pro charta 2.79 g corresp. natrium 4.86 mg. - la colite ulcerosa - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

dr. falk pharma ag - mesalazinum - granulat - mesalazinum 3000 mg, cellulosum microcristallinum, hypromellosum, silica colloidalis anhydrica, acidi ethacrylici et methylis methacrylatis polymerisatum, magnesii stearas, simeticonum, methylcellulosum, acidum sorbicum, carmellosum natricum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, triethylis citras, talcum, acidum citricum, povidonum, e 171, aromatica (vanille-creme), aspartamum 6 mg, ad granulatum, pro charta 5.58 g corresp. natrium 9.72 mg. - la colite ulcerosa - synthetika

Unione Europea - italiano - EMA (European Medicines Agency)

pfizer europe ma eeig - crizotinib - carcinoma, polmone non a piccole cellule - agenti antineoplastici - xalkori as monotherapy is indicated for:the first‑line treatment of adults with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc)the treatment of adults with previously treated anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc)the treatment of adults with ros1‑positive advanced non‑small cell lung cancer (nsclc)the treatment of paediatric patients (age ≥6 to.

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

resinag ag - benzalkonii chloridum, dequalinii chloridum - soluzione - benzalkonii chloridum 0,35 mg, dequalinii chloridum 0.15 mg, sono, excipiens per soluzione pro 1 g corrisp. ethanolum 6 % v/v. - bocca e rachendesinfiziens - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

dr. falk pharma ag - mesalazinum - compresse rivestite con film - mesalazinum 250 mg, natrii carbonas, glycinum, povidonum k 25, cellulosum microcristallinum, silica colloidalis anhydrica, calcii stearas, hypromellosum, Überzug: acidi methacrylici et ethylis acrylatis polymerisatum 1:1, macrogolum 6000, talcum, copolymerum methacrylatis butylati basicum, e 171, e 172 (flavum), pro compresso obducto corresp. natrium 47.72 mg. - la colite ulcerosa - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

dr. falk pharma ag - mesalazinum - compresse rivestite con film - mesalazinum 500 mg, natrii carbonas, glycinum, povidonum k 25, cellulosum microcristallinum, carmellosum natricum conexum, silica colloidalis anhydrica, calcii stearas, hypromellosum, macrogolum 6000, Überzug: acidi methacrylici et methylis methacrylatis polymerisatum 1:1, copolymerum methacrylatis butylati basicum, talcum, macrogolum 6000, e 171, e 172 (flavum), pro compresso obducto corresp. natrium 49 mg. - la colite ulcerosa - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

dr. falk pharma ag - mesalazinum - compresse rivestite con film - mesalazinum 1000 mg, cellulosum microcristallinum, povidonum k 25, carmellosum natricum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, acidi methacrylici et methylis methacrylatis polymerisatum 1:2, calcii stearas, talcum, macrogolum 6000, hypromellosum, silica colloidalis anhydrica, e 172 (flavum), e 171, pro compresso obducto corresp. natrium 5.18 mg. - la colite ulcerosa - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

haleon schweiz ag - lidocaini hydrochloridum monohydricum, diphenhydramini hydrochloridum, benzalkonii chloridum, levomentholum, dexpanthenolum - gel - lidocaini hydrochloridum monohydricum 20 mg, diphenhydramini hydrochloridum 20 mg, benzalkonii chloridum 10 mg, levomentholum 20 mg, dexpanthenolum 30 mg, hydroxypropylcellulosum, alcohol isopropylicus, aqua purificata, ad gelatum pro 1 g. - punture di insetti e irritazioni della pelle - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

haleon schweiz ag - lidocaini hydrochloridum monohydricum, diphenhydramini hydrochloridum, benzalkonii chloridum, levomentholum - soluzione per l'applicazione sulla pelle - lidocaini hydrochloridum monohydricum 10 mg, diphenhydramini hydrochloridum 10 mg, benzalkonii chloridum 10 mg, levomentholum 20 mg, dexpanthenolum, ethanolum 96 per centum 300 mg, aether, alcohol isopropylicus, glycerolum, ammoniae solutio concentrata, aqua purificata ad solutionem pro 1 ml. - per il trattamento di punture di insetti - synthetika